Ophthalmology · New York, NY
NPI
1013095272
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
310 E 14th Street, Room 403
New York, NY, 10003
Phone (212) 979-4410
Groups this clinician bills Medicare through
Medicare paid, 2024
$139K
1,840 services
Medicare patients, 2024
480
Average age 77
Drug cost, 2024
$1.5M
3,340 prescriptions
Company payments, 2025
$4,076
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Douglas F Buxton was code 92012 (ophthalmological e&m), 340 times for 245 patients. In total Douglas F Buxton billed 1,840 services in 51 codes, and Medicare paid $139K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-04-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 340 | 245 | $69.10 | $23K |
| 99213 Office E&M - Established | Office | 231 | 145 | $72.97 | $17K |
| 92014 Ophthalmological E&M | Office | 194 | 181 | $96.80 | $19K |
| 83861 Clinical Chemistry | Office | 190 | 86 | $22.03 | $4,186 |
| 68761 Eye | Office | 106 | 48 | $90.07 | $9,547 |
| 92083 Vision, Hearing, and Speech Services | Office | 84 | 74 | $50.40 | $4,234 |
| 92133 Computerized Ophthalmic Imaging | Office | 82 | 82 | $29.95 | $2,456 |
| 92134 Computerized Ophthalmic Imaging | Office | 76 | 71 | $32.19 | $2,447 |
| 92136 Ultrasound - Nonspecific | Office | 65 | 47 | $22.09 | $1,436 |
| 92286 Standard X-ray | Office | 61 | 51 | $32.97 | $2,011 |
| 92004 Ophthalmological E&M | Office | 49 | 49 | $103.69 | $5,081 |
| 92250 Angiography | Office | 48 | 48 | $28.27 | $1,357 |
| 92020 Ophthalmological E&M | Office | 45 | 43 | $20.85 | $938 |
| 92025 Test - Miscellaneous | Office | 38 | 31 | $26.69 | $1,014 |
| 66984 Cataract Surgery | Facility | 36 | 27 | $472.50 | $17K |
By year: 2022 $183K for 2,003 services; 2023 $164K for 1,939 services; 2024 $139K for 1,840 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 190 | 86 | $22.03 | $4,186 |
Medicare prescription drug claims, 2024
In 2024, the drug Douglas F Buxton prescribed most often to Medicare patients was Restasis (Cyclosporine), with 326 prescriptions and refills. In total Douglas F Buxton wrote 3,340 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Restasis Cyclosporine | 326 | 567 | 105 | $334K |
| Lumigan Bimatoprost | 246 | 487 | 60 | $129K |
| Latanoprost Generic | 198 | 378 | 50 | $1,743 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 170 | 304 | 39 | $2,422 |
| Prednisolone Acetate Generic | 142 | 213 | 73 | $5,681 |
| Vyzulta Latanoprostene Bunod | 142 | 212 | 33 | $55K |
| Azelastine Hcl Generic | 138 | 154 | 50 | $1,872 |
| Cequa Cyclosporine | 132 | 204 | 49 | $117K |
| Timolol Maleate Generic | 132 | 281 | 41 | $2,101 |
| Combigan Brimonidine Tartrate/Timolol | 94 | 185 | 27 | $38K |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 92 | 99 | 55 | $3,470 |
| Xiidra Lifitegrast | 90 | 146 | 26 | $95K |
| Ofloxacin Generic | 86 | 95 | 57 | $1,036 |
| Tyrvaya Varenicline Tartrate | 65 | 71 | 26 | $45K |
| Prolensa Bromfenac Sodium | 58 | 80 | 32 | $20K |
Brand drugs: 2,143 claims; generic drugs: 1,197 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Douglas F Buxton $4,076 ($4,076 in general payments such as food, travel and fees) from 18 companies. The largest payer was Tarsus Pharmaceuticals, Inc. with $736.
| Company | Payments | Amount |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. TARS | 19 | $736 |
| Alcon Vision LLC ALC | 22 | $621 |
| Mallinckrodt Hospital Products Inc. | 19 | $573 |
| Abbvie Inc. ABBV | 8 | $321 |
| Harrow Eye, LLC | 11 | $307 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 13 | $305 |
| Dompe US, Inc. | 7 | $268 |
| Bausch & Lomb Americas Inc. BLCO | 10 | $192 |
| Oyster Point Pharma, Inc. | 7 | $155 |
| Thea Pharma Inc. | 6 | $144 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.